Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature
about
Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.The success of microneedle-mediated vaccine delivery into skin.Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination.Considerations in the use of microneedles: pain, convenience, anxiety and safety.Dissolving Microneedle Patches for Dermal VaccinationThe safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.An update on coating/manufacturing techniques of microneedles.Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice.Recent advances of controlled drug delivery using microfluidic platforms.Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.Long-term stability of influenza vaccine in a dissolving microneedle patch.Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects.Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice
P2860
Q33916017-5A8EE2AD-9845-4352-9B8C-27B4A72D7F2CQ36649709-56E5CE64-4E28-4ABA-A928-0D4CDB0B82E1Q38630763-06C70C09-9C06-4CDD-BEA6-5E4A9F39461EQ38799509-EF2A6273-EB20-4C39-8B46-B7911DE5E6E2Q38818697-5FC512AC-3947-4486-BEE9-800FF13460E9Q38860500-FAF7D0D4-63CA-4AA0-B002-D4F8E1C26502Q39440948-28ECC335-6581-4CAF-BCDC-B16B150E14F0Q40151720-13FF6743-4C07-49E3-8866-B43B8B4C4354Q47101549-39F39EAC-525E-45DB-90F1-492B62DBDE09Q47232251-902DE2DB-BA12-42D7-8000-15004CAC9C9DQ47554106-DA03B4B1-E51F-4CB1-ABB6-F7FFFAD893DCQ47666014-61F260E3-D848-40BB-8088-73437359CBBFQ50533261-4EF13D0B-AB13-4096-8A1E-65C73D3795B7Q50890208-536018F5-75AA-477B-AE99-8BEDA7E755BDQ50962760-38B7953C-5803-48FA-A7B5-BEE05E62737DQ56221441-DA331C6A-CD29-4BFF-92DF-92F6674C4EF7
P2860
Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improved immunogenicity of ind ...... tch stable at room temperature
@ast
Improved immunogenicity of ind ...... tch stable at room temperature
@en
type
label
Improved immunogenicity of ind ...... tch stable at room temperature
@ast
Improved immunogenicity of ind ...... tch stable at room temperature
@en
prefLabel
Improved immunogenicity of ind ...... tch stable at room temperature
@ast
Improved immunogenicity of ind ...... tch stable at room temperature
@en
P2093
P2860
P1476
Improved immunogenicity of ind ...... tch stable at room temperature
@en
P2093
Devin McAllister
E Stein Esser
Elena V Vassilieva
Haripriya Kalluri
Ioanna Skountzou
Joanna A Pulit-Penaloza
Mark R Prausnitz
Misha T Taherbhai
Richard W Compans
Winston P Pewin
P2860
P2888
P304
P356
10.1007/S13346-015-0228-0
P577
2015-08-01T00:00:00Z